Dr Reddy’s

Dr Reddy's Share Price in Focus after Agreement with Gilead Sciences to Produce Lenacapavir

Dr Reddy's Share Price in Focus after Agreement with Gilead Sciences to Produce Lenacapavir

Dr. Reddy’s Laboratories has entered into a significant collaboration with Gilead Sciences to manufacture and commercialize the HIV drug Lenacapavir in India and 120 other countries.

Kushal Gupta: BUY Schaeffler India, Cipla, Dr Reddy’s; SELL Tech Mahindra

Kushal Gupta: BUY Schaeffler India, Cipla, Dr Reddy’s; SELL Tech Mahindra

Market expert Kushal Gupta has suggested three BUY Calls and one SELL Call for today’s trading session. Indian markets are expected to open flat today and we expect a range-bound session.

Chandan Taparia: BUY Dr Reddy’s and Bharti Airtel

Chandan Taparia: BUY Dr Reddy’s and Bharti Airtel

Market expert Chandan Taparia from Motilal Oswal Financial Services has suggested two BUY Calls and no SELL Call for short term traders.

Mitessh Thakkar: BUY HDFC AMC, Dr Reddy’s; SELL UPL and Hindalco

Mitessh Thakkar: BUY HDFC AMC, Dr Reddy’s; SELL UPL and Hindalco

Market expert Mitesh Thakkar has suggested two BUY Calls and two SELL Calls for today’s trade.

Manas Jaiswal: BUY Dr Reddy’s Labs; SELL Adani Ports

Manas Jaiswal: BUY Dr Reddy’s Labs; SELL Adani Ports

Market analyst Manas Jaiswal has suggested one BUY Call and one SELL Call for today’s trade. Indian markets are expected to open flat today after yesterday’s decline during afternoon session.

Chandan Taparia: BUY ICICI Bank, Trent, Dr Reddy’s and Reliance Industries

Chandan Taparia: BUY ICICI Bank, Trent, Dr Reddy’s and Reliance Industries

Market analyst Chandan Taparia has suggested four BUY Calls and no SELL Call for short term investors and traders.

Pages